A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 05 05 2019
accepted: 08 09 2019
entrez: 16 10 2019
pubmed: 16 10 2019
medline: 11 3 2020
Statut: epublish

Résumé

Studies have shown a high risk of tumor development within a bladder diverticulum (BD). We were interested in the relationship between BD and the development of bladder cancer. Herein, we attempted to investigate whether there exists an association between documented BD and subsequent risk of bladder cancer. We identified 10,662 hospitalized urology patients, including 2,134 documented BD patients (study cohort) and 8,528 non-BD subjects (comparison cohort) from Taiwan's National Health Insurance database. Only urology patients were enrolled in the study to minimize selection bias. The two cohorts were frequency-matched 1:4 by age, sex and index-year. Patients with less than one year of follow-up were excluded to avoid inverting cause and effect. Risks of developing bladder cancer were estimated using the Cox proportional hazard regression model. There was an increased bladder cancer risk in the documented BD patients. The incidence of bladder cancer in documented BD patients was 2.60-fold higher than that in the comparison group, and the overall risk-factor-adjusted hazard ratio was 2.63 (95% CI, 1.74-3.97). Moreover, stratified analysis by sex also showed that documented BD patients were at higher risk of subsequent bladder cancer than the comparison cohort. The effect of BD on the risk of bladder cancer was higher in males than in females and was more profound in patients without comorbidities than in those with comorbidities. In this population-based longitudinal study, urology patients with documented BD might have an elevated risk of subsequent bladder cancer. Based on the limitations of the retrospective study design, further studies are required.

Identifiants

pubmed: 31613877
doi: 10.1371/journal.pone.0222875
pii: PONE-D-19-12677
pmc: PMC6793858
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0222875

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

World J Urol. 2009 Jun;27(3):289-93
pubmed: 19219610
N Engl J Med. 2012 Jul 19;367(3):248-57
pubmed: 22808960
Rom J Morphol Embryol. 2010;51(3):543-5
pubmed: 20809034
Nature. 2007 Aug 16;448(7155):767-74
pubmed: 17700693
BJU Int. 2009 May;103(10):1436-9
pubmed: 19076130
Eur Urol Focus. 2015 Aug;1(1):17-27
pubmed: 28723350
Can Urol Assoc J. 2011 Aug;5(4):E60-4
pubmed: 21806896
Urology. 2015 Jun;85(6):1312-8
pubmed: 25863833
Urology. 1989 Dec;34(6):390-5
pubmed: 2595887
J Cancer. 2017 Jan 1;8(1):9-18
pubmed: 28123593
Can J Urol. 2014 Aug;21(4):7393-5
pubmed: 25171286
World J Urol. 2018 Jun;36(6):931-938
pubmed: 29427001
Med Princ Pract. 2005 Mar-Apr;14(2):121-4
pubmed: 15785107
J Urol. 1967 Sep;98(3):349-52
pubmed: 4963798
Eur J Cancer. 2015 Oct;51(15):2217-2230
pubmed: 26421824
Int J Cancer. 2013 Jan 1;132(1):182-8
pubmed: 22510866
Nat Rev Mol Cell Biol. 2007 Sep;8(9):715-22
pubmed: 17717516
Br J Urol. 1962 Sep;34:286-98
pubmed: 13959030
Acta Pathol Jpn. 1984 Mar;34(2):417-24
pubmed: 6430029
J Cancer Res Ther. 2013 Jan-Mar;9(1):151-3
pubmed: 23575101
JAMA. 2011 Aug 17;306(7):737-45
pubmed: 21846855
Hinyokika Kiyo. 2017 May;63(5):211-215
pubmed: 28625029
Int J Urol. 2017 Aug;24(8):594-600
pubmed: 28734027
Eur Urol. 2013 Feb;63(2):234-41
pubmed: 22877502
Br J Urol. 1981 Apr;53(2):141-3
pubmed: 6786409
J Urol. 2015 Aug;194(2):527-8
pubmed: 25986516
Am J Kidney Dis. 2007 Jan;49(1):46-55
pubmed: 17185145
Nephron. 2018;140(3):175-184
pubmed: 30138926
Diabetologia. 2011 Aug;54(8):2009-15
pubmed: 21544514
J Urol. 2003 Nov;170(5):1761-4
pubmed: 14532771
Urologia. 2011 Jan-Mar;78(1):17-21
pubmed: 21452155
Nat Rev Urol. 2014 Jul;11(7):383-90
pubmed: 24934450
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Int Urol Nephrol. 2016 Jun;48(6):993-9
pubmed: 26995008
Lancet. 2008 Jun 28;371(9631):2173-82
pubmed: 18586172
Eur Urol. 2007 Mar;51(3):690-7; discussion 697-8
pubmed: 16904815
Urology. 1987 Nov;30(5):453-7
pubmed: 3118548
Am J Kidney Dis. 2006 Nov;48(5):727-38
pubmed: 17059992
Pan Afr Med J. 2015 Apr 16;20:378
pubmed: 26185568

Auteurs

Chu-Wen Fang (CW)

Division of Urology, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan.

Vivian Chia-Rong Hsieh (VC)

Department of Health Services Administration, China Medical University, Taichung, Taiwan.

Steven Kuan-Hua Huang (SK)

Division of Urology, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan.

I-Ju Tsai (IJ)

Management Office for Health Data, China Medical University and Hospital, Taichung, Taiwan.

Chih-Hsin Muo (CH)

Management Office for Health Data, China Medical University and Hospital, Taichung, Taiwan.

Shih-Chi Wu (SC)

Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
Trauma and Emergency Center, China Medical University Hospital, Taichung, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH